IMPROVING DIABETES CARE FOR ADULTS: A Population-Based Approach Patrick J. O’Connor, MD, MPH Senior Clinical Investigator HealthPartners Research Foundation.

Slides:



Advertisements
Similar presentations
Organization of Diabetes Care Chapter 6 Maureen Clement, Betty Harvey, Doreen M Rabi, Robert S Roscoe, Diana Sherifali Canadian Diabetes Association 2013.
Advertisements

10 Points to Remember for the Management of Overweight and Obesity in Adults Management of Overweight and Obesity in Adults Summary Prepared by Elizabeth.
THE ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES STUDY (ACCORD)
99.98% of the time patients are on their own “The diabetes self-management regimen is one of the most challenging of any for chronic illness.” 0.02% of.
Schaller Anderson Presents to March 8, Today’s Objectives Let’s talk about our teachers and school workers and their health care Do you know WHO.
CVD risk estimation and prevention: An overview of SIGN 97.
Mississippi Task Force on Heart Disease and Stroke Prevention 2008 Current Status J. Clay Hays, Jr, MD, FACC.
CVD prevention & management: a new approach for primary care Rod Jackson School of Population Health University of Auckland New Zealand.
2.11 Conduct Medication Management University Medical Center Health System Lubbock, TX Jason Mills, PharmD, RPh Assistant Director of Pharmacy.
Stroke Issues & prevention. Agenda  Impact of Stroke –Definitions –Epidemiology –Risk factors  Management of Stroke –Acute management –Primary & Secondary.
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program Clinical Goals for the Healthy.
Overview of the CVD Risk Reduction Demonstration Project Kelly Acton, MD, MPH, FACP IHS Division of Diabetes Treatment & Prevention.
CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.
Community-based Falls Prevention Falls Preconference Session August 20, 2007 Pam Van Zyl York, MPH, PhD, RD, LN Minnesota Department of Health.
Diabetes Mellitus Type 2
Facts and Fiction about Type 2 Diabetes Michael L. Parchman, MD Department of Family & Community Medicine September 2004.
Cohort Studies Hanna E. Bloomfield, MD, MPH Professor of Medicine Associate Chief of Staff, Research Minneapolis VA Medical Center.
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
Racial/Ethnic Disparities in Health Care: Narrowing the Gap through Solutions Joseph R. Betancourt, M.D., M.P.H. Director, The Disparities Solutions Center.
ACCORD - Action to Control Cardiovascular Risk in Diabetes ADVANCE - Action in Diabetes to Prevent Vascular Disease VADT - Veterans Administration Diabetes.
Health Disparities in Cardiovascular Disease Paula A. Johnson, MD, MPH Chief, Division of Women’s Health; Executive Director, Connors Center for Women’s.
Minimally Invasive Surgery Symposium Modest Weight Loss in T2 DM: Lessons from the Look AHEAD Trial Donna H. Ryan, MD Pennington Biomedical Research Center.
{ A Novel Tool for Cardiovascular Risk Screening in the Ambulatory Setting Guideline-Based CPRS Dialog Adam Simons MD.
Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes.
... a KAISER PERMANENTE Innovation IndiGO: Tailoring Guidelines to Individuals David M Eddy MD PhD Founder and Chief Medical Officer Emeritus Archimedes.
Rapid E clinical guidance in the management of Type 2 diabetes New Zealand Guidelines Group.
Heart Health Project University of Pennsylvania School of Medicine American Heart Association Pennsylvania State University Funded by the Robert Wood Johnson.
Risk estimation and the prevention of cardiovascular disease SIGN 97.
Using research to inform and change primary care Professor James Dunbar Greater Green Triangle UDRH
Joint Effects of Routine Blood Pressure Lowering and Intensive Glucose Control ADVANCE Adapted from EASD 2008.
EXAM 1.A normal adult should have their BP checked at least how often? 2.What level of CVD risk over 10 years is considered high risk for primary prevention?
A Coordinated Approach to Cardiovascular Care Sharon Levine MD Associate Executive Director The Permanente Medical Group Kaiser Permanente Bay Area Council.
M Mohsen Ibrahim, MD CARDIOLOGY DEPARTMENT-CAIRO UNIVERSITY MINIMAL vs OPTIMAL MEDICAL CARE.
Effect of Hypertension and Dyslipidemia on glycemic control among Type 2 Diabetes patients in Thailand Dr. Mya Thandar Dr.PH. Batch 5 1.
Modern Management of Cholesterol in the High-Risk Patient.
1 NHLBI/NEI National Institutes of Health NHLBI/NEI National Institutes of Health.
10 Points to Remember on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in AdultsTreatment of Blood Cholesterol to Reduce.
VA/DoD 2006 Clinical Practice Guideline For Screening and Management of Overweight and Obesity Guideline Summary: Key Elements.
Peter Emery, MD Specialist in Clinical Hypertension InterMed Portland, ME.
Obesity Symposium-Ignite the fight against Obesity: Advocate’s Approach to Population Health Management September 26 th 2014 Pankaj Patel MD MSc Senior.
WHIRLPOOL CORPORTATION  CONFIDENTIAL A COMMUNITY PARTNERSHIP: The Whirlpool PCMH Journey Susan Pavlopoulos Senior Manager// Global Benefits April 28,
New Approaches to Disease Management Get Connected Knowledge Forum Larry G. Anderson MD MMC Physician-Hospital Organization June, 2005.
NATIONAL D I ABET ES DEI TACUON PROGRA M Changing the way diabetes is treated.
Studying mortality trends: The IMPACT CHD Policy Model
Cardiac Rehabilitation 2011 Update for Primary Care Providers Douglass A Morrison, MD, PhD Cardiac Rehabilitation, Medical Director Yakima Regional and.
Effect of Hypertension and Dyslipidemia on glycemic control among Type 2 Diabetes patients in Thailand Dr. Mya Thandar DrPH Batch 5 1.
Clinic Characteristics that May Impact Diabetes Care Outcomes and Costs: Conceptual Approach Patrick J. O’Connor MD MPH Robin R. Whitebird Ph.D. Jon C.
Individualization Strategies for Older Patients with Diabetes Elbert S. Huang, MD MPH FACP University of Chicago.
Community Outreach to Reduce Disparities in Cardiovascular & Diabetes Morbidity & Mortality in the South Bronx Michael Alderman, MD Michelle Johnson, MD,
Definition of the ‘health transition’ Trends of disease patterns in populations The 4 stages of the epidemiological transition The cardiovascular disease.
Diabetes Mellitus 101 for Cardiologists (and Alike): 2015
Self-Management Support Strategies for Improving your Patients’ CVD Risk Bonnie Jortberg PhD, RD, CDE Robyn Wearner RD, MA Department of Family Medicine.
Part 3. Diabetes Report Card: HbA 1c Levels in the United States Hoerger TJ, et al. Diabetes Care. 2008;31: Patients (%) HbA 1c (%)
Ross T. Tsuyuki, BSc(Pharm), PharmD, MSc, FCSHP, FACC Yazid NJ Al Hamarneh, BPharm, PhD Charlotte Jones, MD, PhD, FRCP(C) Brenda Hemmelgarn, MD, PhD, FRCP(C)
The Burden of Chronic Diseases in the Developing World Stephen J. Spann, M.D., M.B.A. Professor and Chairman Department of Family and Community Medicine.
Improving Adherence in Type 2 Diabetes Mellitus ALLISON PETZNICK DO NOMS FAMILY MEDICINE SANDUSKY, OH.
The MICRO-HOPE. Microalbuminuria, Cardiovascular and Renal Outcomes in the Heart Outcomes Prevention Evaluation Reference Heart Outcomes Prevention Evaluation.
Global health in the news h/study-shows-spread-of-cigarettes-in- china.html?ref=health&_r=0.
Chapter 7: Epidemiology of Chronic Diseases. “The Change You Like to See….” (1 of 3) Chronic diseases result from prolongation of acute illness. – With.
Clinical Quality Improvement: Achieving BP Control
Blood Pressure and Lipid Trials: Rationale, Importance and Design
Our unique strategy Seamless integration = Total health engagement
ACCORD Design and Baseline Characteristics
Diabetes Journal Club Carina Signori Endocrinology Fellow
Diabetes Health Status Report
Macrovascular Complications Microvascular Complications
Cardiovascular Disease (CVD) in Texas
Section VII: Summary New focus on treating hypertension beyond the numbers Content Points: In view of current clinical understanding of the link between.
PowerPoint 16:9 Screen Ratio Template *
Nutrition Interventions to Improve Quality of Care
Presentation transcript:

IMPROVING DIABETES CARE FOR ADULTS: A Population-Based Approach Patrick J. O’Connor, MD, MPH Senior Clinical Investigator HealthPartners Research Foundation

Today’s Objectives – Leadership and Resources: The Burden of Diabetes and the Cost of Doing Nothing – Population Health Impact and Cost of Competing Diabetes Improvement Priorities – The “Enhanced Primary Care Model” – Results and Future Challenges

CDC, Burden of Diabetes in the US Morbidity and Mortality – Mortality: #3 cause, with 182,000 deaths each year – Prevalence doubling every years – The death rate in the diabetic population is slowly decreasing for men but increasing for women – 70% of deaths in adults with DM are related to MI or CVA – Clinical trials provide evidence that control of hyperglycemia, dyslipidemia, and hypertension and use of ASA lower the risk of macro and micro complications.

Primary Prevention of Type 2 Diabetes – Physical Activity – Weight Management – Finnish Study 57% Reduction in Incidence - mean age around 60 years with IGT - dietary instruction 8 weekly sessions, then q 3 mo - structured physical activity 3 x a week - lost about 5 Kg.

Economic Burden of Diabetes in Adults The Cost of Doing Nothing

CHD & DM DM only HBA 1c

Selecting Improvement Goals All Goals Are Not Equal

Prioritizing Diabetes Treatment Goals – Gap Analysis – Consider Population Health Benefits--NNT, Events – Consider Incremental Direct Costs to Payers – Clinical Strategies: Glycemic control Lipid control Blood pressure control Aspirin use

Percent of Adult Diabetes Patients NOT at Goal

Number Needed to Treat for 5 Years to Prevent Progression of One Microvascular Complication NNT - 10/5 mm Hg- 1% HBA1c

Micro Events Averted Relative Impact of Various DM Improvement Strategies on Population Health Outcomes Events Averted per 10,000 Adults with DM Over 5 Years Time

Number Needed to Treat for 5 Years to Prevent One Heart Attack or Stroke

Macro Events Averted Relative Impact of Various DM Improvement Strategies on Population Health Outcomes Events Averted per 10,000 Adults with DM Over 5 Years Time

Direct Costs of DM Improvement Strategies

5-Year Net Cost to Health Plan for Every 10,000 Adults with Diabetes for Selected Diabetes Care Improvement Strategies (Increased Treatment Costs - Savings from Averted Events)

Diabetes Improvement Goals – Various evidence-based diabetes clinical care recommendations have very different costs and very different benefits, calculated on a population basis – Aspirin use and blood pressure control have the most favorable ratio of benefits to costs

Diabetes Improvement Goals – Lipid control in heart patients gives more benefit at lower cost than lipid control in patients without heart disease. – Glycemic control is an important element of diabetes care. Costs and benefits of glycemic control are sensitive to the HBA1c goal of care.

The Enhanced Primary Care Model Better than Carve Out Disease Management

Enhanced Primary Care Model--Advantages - Invest in Care System - -Extend Benefits to Multiple Clinical Domains - Strengthen, not Weaken Continuity and Coordination of Care - Seamless to Patients - Better Population Penetration

Successful Chronic Disease Care: Messages to Docs – Do This, or Die (Economic and Breadth of Practice Issues) – Don’t Blame Patients---Solve Problems – Doing things together is more important than doing things alone - Partner with the Patient - Team up with nurses, educators, other docs

Data and Information Systems Support Road Map Guidelines Effective Care Team Activated Patient The Enhanced Primary Care Model-- Foundations CQI

Registry Prioritize Monitor Planned Care & Active Outreach The Enhanced Primary Care Model-- Operation CQI

Active Registry or Risk List – For each doc and each clinic, new every 3 months – List of DM patients from highest to lowest HBA1c (later added CHD status and LDL-levels) – Permits proactive, population-based management – ID diabetes is 91% sensitive with 94% positive predictive value – Generally positive response from docs

Monitor Clinical Status or Risk – HBA1c, LDL, CHD status – Want BP control, aspirin use, smoking status – Key Decision: What clinical domain to emphasize - Do what is easy? Or - Do what is right?

Prioritize Patients Based on Risk – Novel concept to many nurses and educators – Use both clinical status and “readiness to change” – Focus most energy on those ready to change (varies by specific issue--smoking, diet, activity, DM care in general) – Those in worst shape most ready to change – Do NOT ignore those who are doing well--if so, doomed to clinical success and financial disaster (pipeline effect)

Active Outreach -- Proactive Care – Need more than just docs to do this – Empower nurses and educators – Respect patient’s constitutional rights and privacy – Calls come directly from clinic, usually a nurse pt knows – First check: Medication intensity – Second check: Motivational and educational needs

Visit Planning – A form of decision support – Do the hard way, by hand--too expensive – Do the easy way AMR/automated systems – Flow sheets are the poor clinic’s solution to this problem – Have not done yet, but results better than those who have made this a primary emphasis of improvement – AMR clinic with DM GL is good, but not best clinic

N = % N = % HBA1c Test Rate

Cross-Sectional Change in Mean HBA 1c

Cohort LDL Changes

Chronic Disease Care – Identify Problems – Prioritize Problems in Partnership with Patient – Initiate Treatment – Monitor Response – Titrate to Goal

Summary – 40% reduction in macrovascular risk – 25% reduction in microvascular risk – In well organized (enhanced) primary care clinics with a part time on-site DM nurse educator (not necessarily CDE) – Patient Education NOT associated with significantly better A1c – Improvement NOT due to: carve out disease management, endocrinology consults (<5% per year), less than 2% of patients use either TZD, alpha glucosidase, or meglitamides

Key Components – Medical Group Physician Involvement and Leadership – Resources--show ”cost of doing nothing” – Intelligent use of information: identify patients with diabetes, monitor, prioritize, proactive outreach & visit planning – Organize clinics to give proactive, population-based care – Intensify Treatment--Titrate to Goal – Consider Evidence AND Value when selecting improvement goals

Future Directions – Variation Continues--Plenty of room for more improvement – Ascertain most appropriate level for QI intervention – Focus on blood pressure reduction – Focus on “Patient Activation” – Focus on Visit Planning – Focus on Physician decision making process and methods to change physician behavior – Development of “Patient Archetypes” to advance care